Article
Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.
Digestive diseases and sciences - 1 Jun 1994
Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K
Abstract excerpt
Using conventional statistical analysis and multiple regression analysis, we investigated the viral and host factors that influence the response to recombinant interferon-alpha 2a therapy in patients with chronic hepatitis C. A total of 36 patients was randomly assigned to three administration schedules, 12 patients in each. Response to treatment was set as the criterion variable. Four variables were...
Topics
- Adult
- Base Sequence
- Chronic Disease
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus
- Hepatitis C
- Humans
- Interferon Type I
- Liver
- Male
